Schedule 13G ownership disclosure

Pandion Therapeutics Inc

Security class unavailable · CUSIP: 698340106

Event date: 2020-07-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
3.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-20-000636
Form type
SC 13G
Filer
ORBIMED ADVISORS LLC
CIK
CIK 1055951
Filed
Jul 28, 2020
Reporting period
Jul 17, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub